Patents by Inventor John A. Mullan

John A. Mullan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8082196
    Abstract: The invention provides a financial management system wherein a real bank account is notionally sub-divided into virtual sub-accounts and transactions are effected between the virtual sub-accounts without affecting the operation of the real bank account, such a system allowing a customer to maintain an automatically updated model of the customer's finances within the single account, thus assisting visualization of his or her financial position, while retaining the benefit of the single account.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: December 20, 2011
    Assignee: The One Account Limited
    Inventors: Anthony John Mullan, Richard Jeremy Heap
  • Publication number: 20090203033
    Abstract: The invention provides an isolated nucleic acid characteristic of human amyloid precursor protein 770 including the nucleotides encoding codon 670 and 671, wherein the nucleic acid encodes an amino acid other than lysine at codon 670 and/or an amino acid other than methionine at codon 671. Also provided is a method of diagnosing or predicting a predisposition to Alzheimer's disease, comprising detecting in a sample from a subject the presence of a mutation at a nucleotide position corresponding to codons 670 and/or 671 of amyloid precursor protein or fragment thereof, the presence of the mutation indicating the presence of or a predisposition to Alzheimer's disease.
    Type: Application
    Filed: April 24, 2009
    Publication date: August 13, 2009
    Inventor: MICHAEL JOHN MULLAN
  • Patent number: 7538258
    Abstract: The invention provides an isolated nucleic acid characteristic of human amyloid precursor protein 770 including the nucleotides encoding codon 670 and 671, wherein the nucleic acid encodes an amino acid other than lysine at codon 670 and/or an amino acid other than methionine at codon 671. Also provided is a method of diagnosing or predicting a predisposition to Alzheimer's disease, comprising detecting in a sample from a subject the presence of a mutation at a nucleotide position corresponding to codons 670 and/or 671 of amyloid precursor protein or fragment thereof, the presence of the mutation indicating the presence of or a predisposition to Alzheimer's disease.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: May 26, 2009
    Assignee: Alzheimer's Institute of America, Inc.
    Inventor: Michael John Mullan
  • Patent number: 6818448
    Abstract: The invention provides an isolated nucleic acid characteristic of human amyloid precursor protein 770 including the nucleotides encoding codon 670 and 671, wherein the nucleic acid encodes an amino acid other than lysine at codon 670 and/or an amino acid other than methionine at codon 671. Also provided is a method of diagnosing or predicting a predisposition to Alzheimer's disease, comprising detecting in a sample from a subject the presence of a mutation at a nucleotide position corresponding to codons 670 and/or 671 of amyloid precursor protein or fragment thereof, the presence of the mutation indicating the presence of or a predisposition to Alzheimer's disease.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: November 16, 2004
    Assignee: Alzheimer's Institute of America, Inc.
    Inventor: Michael John Mullan
  • Publication number: 20030165958
    Abstract: Model systems of Alzheimer's disease comprise a DNA sequence encoding an amyloid precursor protein (APP) isoform or fragment that has an amino acid substitution. The substituted amino acid may be other than valine at the amino acid position corresponding to amino acid residue position 717 of APP770. Methods of determining genetic predisposition to Alzheimer's disease are also disclosed.
    Type: Application
    Filed: February 3, 2003
    Publication date: September 4, 2003
    Applicant: Elan Pharmaceuticals
    Inventors: John Anthony Hardy, Marie-Christine Chartier-Harlin, Alison Mary Goate, Michael John Owen, Michael John Mullan
  • Publication number: 20020138398
    Abstract: A method and apparatus are provided in an integrated platform for automatic network data transport, procurement contracting, provisioning, contract fulfillment, customized billing feeds, and securing of bandwidth derivative financial instruments. This is achieved through the use of multiple bandwidth exchange nodes within carrier-neutral facilities at geographically separate locations. The system and apparatus provide contracted bandwidth between nodes as negotiated by virtual user and carrier agents, enabling for the securing of capacity futures contracts as well as a real-time means to determine current market pricing for bandwidth contracts and derivatives. This system creates the basis for a liquid bandwidth commodity and derivatives marketplace.
    Type: Application
    Filed: May 3, 2001
    Publication date: September 26, 2002
    Inventors: Dan M. Kalin, John A. Mullan
  • Publication number: 20020133834
    Abstract: The invention provides an isolated nucleic acid characteristic of human amyloid precursor protein 770 including the nucleotides encoding codon 670 and 671, wherein the nucleic acid encodes an amino acid other than lysine at codon 670 and/or an amino acid other than methionine at codon 671. Also provided is a method of diagnosing or predicting a predisposition to Alzheimer's disease, comprising detecting in a sample from a subject the presence of a mutation at a nucleotide position corresponding to codons 670 and/or 671 of amyloid precursor protein or fragment thereof, the presence of the mutation indicating the presence of or a predisposition to Alzheimer's disease.
    Type: Application
    Filed: February 16, 2001
    Publication date: September 19, 2002
    Applicant: Alzheimer's Institute of America, Inc.
    Inventor: Michael John Mullan
  • Patent number: 6300540
    Abstract: Model systems of Alzheimer's disease comprise a DNA sequence encoding an amyloid precursor protein (APP) isoform or fragment that has an amino acid substitution. The substituted amino acid may be other than valine at the amino acid position corresponding to amino acid residue position 717 of APP770. Methods of determining genetic predisposition to Alzheimer's disease are also disclosed.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 9, 2001
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: John Anthony Hardy, Marie-Christine Chartier-Harlin, Alison Mary Goate, Michael John Owen, Michael John Mullan
  • Patent number: 5877015
    Abstract: Model systems of Alzheimer's disease comprise a DNA sequence encoding an amyloid precursor protein (APP) isoform or fragment that has an amino acid substitution. The substituted amino acid may be other than valine at the amino acid position corresponding to amino acid residue position 717 of APP770. Methods of determining genetic predisposition to Alzheimer's disease are also disclosed.
    Type: Grant
    Filed: January 21, 1992
    Date of Patent: March 2, 1999
    Assignee: Imperial College of Science, Technology of Medicine
    Inventors: John Anthony Hardy, Marie-Christine Chartier-Harlin, Alison Mary Goate, Michael John Owen, Michael John Mullan
  • Patent number: 5795963
    Abstract: The invention provides an isolated nucleic acid characteristic of human amyloid precursor protein 770 including the nucleotides encoding codon 670 and 671, wherein the nucleic acid encodes an amino acid other than lysine at codon 670 and/or an amino acid other than methionine at codon 671. Also provided is a method of diagnosing or predicting a predisposition to Alzheimer's disease, comprising detecting in a sample from a subject the presence of a mutation at a nucleotide position corresponding to codons 670 and/or 671 of amyloid precursor protein or fragment thereof, the presence of the mutation indicating the presence of or a predisposition to Alzheimer's disease.
    Type: Grant
    Filed: March 13, 1997
    Date of Patent: August 18, 1998
    Assignee: Alzheimer's Institute of America
    Inventor: Michael John Mullan
  • Patent number: 5493564
    Abstract: A method and apparatus for global routing of electronic messages includes maintaining external and internal address information for each user of a messaging system, along with means for associating the external and internal address for any given user. Upon receipt of a signal embodying a message, the messaging system accesses a conversion table to translate the external address for the recipient to its associated internal address. Similarly, for messages being sent to outside recipients, the messaging system accesses a conversion table to translate the internal address for the originator of the message to an associated external address. For messages sent between users of the same system where the originator specifies an external address for the intended recipient, a dual translation may be performed to convert the internal originator address to an external address and the external recipient address to an internal address.
    Type: Grant
    Filed: March 25, 1994
    Date of Patent: February 20, 1996
    Assignee: Sprint International Communications Corp.
    Inventor: John A. Mullan
  • Patent number: 5459717
    Abstract: A method and apparatus for routing a message embodied in a signal received by an electronic messaging system includes formatting a search key using address codes parsed from a user address specified in the message, where each of the address codes corresponds to a different level of specificity for the user address. An attempt is made to retrieve a record from a database of routing information using the search key. If no record is found, the address code corresponding to the most detailed level of specificity in the user address is stripped from the search key and another attempt is made to retrieve a record. This process continues until a record is successfully retrieved from the database or a predetermined base level of specificity is reached.
    Type: Grant
    Filed: March 25, 1994
    Date of Patent: October 17, 1995
    Assignee: Sprint International Communications Corporation
    Inventors: John A. Mullan, Fernando Roger